emerg
resist
microorgan
antibiot
directli
relat
excess
use
drug
upper
airway
infect
common
children
nurs
babi
may
present
upper
airway
infect
year
case
sinus
acut
otiti
media
tonsil
caus
virus
cours
selflimit
howev
common
see
antibiot
use
treat
infect
especi
three
situat
patient
complain
throat
pain
children
hyperem
tympan
membran
cough
exud
sinu
radiograph
show
opac
lack
knowledg
natur
progress
upper
airway
infect
poor
valid
clinic
histori
physic
examin
epidemiolog
data
associ
excess
use
antibiot
also
equal
import
factor
lead
abus
use
medic
low
predict
valu
clinic
sign
differenti
viral
bacteri
tonsil
absenc
easi
low
cost
laboratori
test
diagnos
upper
airway
infect
etiolog
difficulti
access
medic
servic
gener
insecur
risk
complic
fals
expect
antibiot
use
viral
upper
airway
infect
avoid
futur
complic
difficulti
interpret
radiolog
exam
may
help
differenti
viral
sinus
bacteri
allerg
sinus
review
author
critic
analyz
result
random
control
studi
clinic
laboratori
criteria
use
diagnosi
treatment
tonsil
sinus
acut
otiti
media
base
pubm
scielo
databas
tonsil
may
caus
varieti
microorgan
tabl
group
betahemolyt
streptococcu
group
streptococcu
pyogen
ga
howev
common
etiolog
agent
may
lead
suppur
complic
nonsuppur
condit
rheumat
fever
acut
glomerulonephr
estim
tonsil
case
children
age
year
caus
virus
howev
case
treat
antibiot
excess
use
antibiot
treatment
pharyngotonsil
mayb
due
difficulti
differenti
viral
tonsil
caus
group
betahemolyt
streptococcu
gabh
expect
antibiot
may
avoid
complic
rheumat
fever
metaanalysi
compris
studi
total
patient
throat
pain
reveal
antibiot
treatment
reduc
risk
rheumat
fever
nearli
rr
ci
associ
lower
risk
glomerulonephr
also
fewer
suppur
complic
acut
otiti
media
rr
ci
acut
sinus
rr
ci
peritonsillari
abscess
rr
ci
decreas
symptom
pain
fever
seen
third
day
antibiotictr
group
half
placebotr
patient
alreadi
asymptomat
one
week
patient
treat
antibiot
symptomfre
six
patient
treat
antibiot
one
decreas
symptom
third
day
treatment
impact
antibiot
symptom
signific
patient
posit
oropharyng
swab
streptococci
analyz
main
purpos
treat
acut
tonsil
case
antibiot
reduc
possibl
suppur
nonsuppur
complic
associ
gabh
decreas
transmiss
bacterium
commun
although
mani
clinic
criteria
differenti
bacteri
viral
tonsil
tabl
sensit
identifi
bacteri
tonsil
remain
low
antigendetect
rapid
strep
test
posit
clinic
assess
sensit
specif
posit
predict
valu
neg
predict
valu
preval
gabh
studi
done
sao
paulo
aim
compar
cultur
molecular
hybrid
rapid
strep
test
detect
gabhsantigen
children
age
year
acut
pharyngotonsil
gabh
found
cultur
sampl
test
molecular
hybrid
fast
antigen
detect
test
statist
signific
differ
among
three
method
anoth
studi
subject
age
year
found
rapid
strep
test
sensit
specif
neg
posit
predict
valu
although
tonsillari
cultur
consid
gold
standard
final
etiolog
diagnosi
gabh
tonsil
accuraci
test
easili
avail
result
slow
american
academi
pediatr
recommend
use
fast
detect
diagnost
test
specif
group
streptococc
carbohydr
enzym
immunoassay
latex
agglutin
differenti
viral
bacteri
tonsil
test
provid
prompt
result
sensit
specif
diagnosi
streptococc
tonsil
import
note
neither
oropharyng
cultur
rapid
strep
test
detect
streptococci
abl
differenti
patient
diseas
gabh
carrier
develop
countri
rapid
strep
test
detect
oropharyng
streptococc
antigen
use
given
high
sensit
brazil
although
test
use
privat
clinic
avail
public
health
unit
diagnosi
thu
still
base
clinic
criteria
sinc
criteria
sensit
detect
gabh
tonsil
given
risk
rheumat
fever
develop
countri
aforement
test
made
avail
clinician
work
public
healthcar
may
avoid
use
antimicrobi
excess
prompt
treatment
gabh
essenti
prevent
rheumat
fever
sinc
incid
complic
low
therapi
initi
nine
day
follow
onset
symptom
although
benefit
avoid
symptom
tonsil
earli
therapi
drastic
reduc
transmiss
strain
caus
rheumat
fever
acut
glomerulonephr
risk
gabh
transmiss
close
environ
household
school
high
risk
fall
markedli
within
hour
penicillin
therapi
hand
earli
treatment
streptococc
infect
associ
lower
serolog
respons
increas
recurr
rate
infect
tabl
clinic
featur
bacteri
tonsil
netherland
children
age
year
least
two
criteria
suggest
bacteri
infect
complaint
throat
pain
least
seven
day
evalu
effect
three
seven
day
penicillin
therapi
assess
use
antibiot
decreas
symptom
complic
rate
regardless
whether
children
confirm
unconfirm
gabh
infect
howev
children
posit
oropharyng
cultur
gabh
treat
antibiot
higher
recurr
rate
tonsil
may
possibl
low
complic
detect
rate
associ
small
sampl
size
low
preval
countri
nephrogen
strain
associ
rheumat
fever
thu
inadequ
diagnosi
treatment
streptococc
tonsil
may
increas
risk
region
high
preval
rheumat
fever
studi
compris
children
three
countri
undertaken
assess
world
health
organ
criteria
identifi
children
gabh
tonsil
studi
reveal
percentag
gabh
tonsil
rang
brazil
croatia
although
world
health
organ
criteria
highli
specif
bacterium
sensit
lower
author
conclud
sensit
criteria
need
identifi
gabh
especi
place
incid
rheumat
fever
high
sweden
gabh
found
oropharyng
cultur
children
age
year
acut
tonsil
among
children
highli
suggest
criteria
bacteri
infect
sensit
specif
posit
predict
valu
neg
predict
valu
treat
gabh
tonsil
adequ
import
diagnos
condit
correctli
unfortun
occur
practic
mani
children
throat
pain
given
inappropri
antibiot
erad
gabh
oropharynx
treat
shorter
recommend
period
incorrect
dose
dose
interv
variou
antibiot
abl
erad
gabh
may
given
shorter
regimen
singl
daili
dose
may
increas
complianc
howev
pyogen
remain
highli
sensit
penicillin
cephalosporin
although
macrolid
may
facilit
treatment
streptococc
infect
lowdos
azithromycin
regimen
appear
inadequ
treat
gabh
tonsil
furthermor
macrolid
resist
directli
associ
use
advis
restrict
use
drug
patient
allerg
penicillin
present
recur
tonsil
metanalysi
studi
compris
patient
show
treatment
mgkg
azithromycin
superior
day
treatment
penicillin
cephalosporin
failur
erad
gabh
five
time
frequent
antibiot
compar
azithromycin
azithromycin
given
dose
mgkg
per
treatment
effect
three
time
lower
compar
ten
day
treatment
antibiot
treatment
tonsil
azithromycin
dose
mgkg
children
mgday
three
day
adult
superior
therapi
antibiot
penicillin
cephalosporin
also
advantag
reduc
complianc
problem
studi
done
usa
europ
shown
cephalosporin
three
four
time
effect
oral
penicillin
erad
pyogen
demonstr
laboratori
metanalysi
compris
studi
patient
compar
cephalosporin
day
penicillin
day
demonstr
europ
bacteriolog
failur
rate
cephalosporin
time
lower
usa
failur
rate
time
lower
studi
compar
short
cephalosporin
treatment
day
classic
oral
penicillin
treatment
day
also
show
lower
bacteriolog
failur
rate
cephalosporin
although
decreas
failur
rate
lower
seen
cephalosporin
given
day
studi
done
teenag
adult
gabhscaus
tonsil
reveal
clindamycin
dose
bid
equal
effect
compar
associ
amoxicillinclavulan
although
result
shown
recent
antibiot
equal
effect
penicillin
treatment
gabh
tonsil
born
mind
drug
costli
cephalosporin
macrolid
higher
impact
select
resist
strain
compar
betalactam
drug
betalactam
antibiot
remain
first
choic
treatment
bacteri
tonsil
given
lower
cost
lower
preval
resist
pyogen
drug
final
import
underlin
need
caution
use
nonsteroid
antiinflammatori
drug
treatment
children
fever
symptom
remain
caus
sought
viral
infect
atyp
bacteria
common
cold
frequent
infecti
diseas
children
adult
often
caus
persist
nasal
exud
seven
ten
day
nasal
mucosa
continu
paranas
caviti
viral
infect
may
thu
also
lead
sinu
diseas
acut
bacteri
sinus
one
frequent
complic
common
cold
alway
suspect
children
cough
purul
nasal
exud
last
day
fever
persist
recur
fourth
day
upper
airway
infect
plain
radiograph
paranas
caviti
use
diagnosi
acut
bacteri
sinus
sinc
common
cold
allerg
condit
may
caus
paranas
caviti
opac
radiograph
distinguish
radiolog
find
acut
bacteri
sinus
acut
bacteri
sinus
suspect
symptom
recur
best
exam
comput
tomographi
although
mani
children
cough
persist
nasal
exud
treat
antibiot
drug
often
littl
effect
solv
problem
studi
shown
symptom
resolv
one
eight
treat
children
ic
recent
random
control
studi
compris
children
nasal
symptom
imag
exam
ultrasound
paranas
radiograph
suggest
sinus
reveal
efficaci
therapi
cefuroxim
axetil
bid
day
similar
placebo
signific
differ
found
proport
complet
cure
children
two
week
cefuroxemin
reduc
symptom
case
ic
tonsil
choic
best
therapi
regimen
children
suspect
bacteri
sinus
vari
differ
place
recommend
amoxicillin
usual
dosag
advoc
use
wide
spectrum
antibiot
high
dose
amoxicillin
clavulan
cephalosporin
macrolid
analysi
studi
reveal
clarithromycin
compar
amoxicillin
amoxicillinclavulan
littl
ad
benefit
reduc
symptom
rhinosinus
although
clarithromycin
effect
safe
treat
rhinosinus
higher
cost
compar
betalactam
antibiot
taken
account
appli
hew
drug
telithromycin
shown
effect
adult
dose
day
five
day
recommend
treatment
acut
sinus
includ
hyperton
salin
solut
topic
nasal
corticosteroid
studi
compar
approach
antibiot
placebo
done
select
adult
group
acut
otiti
media
one
common
infect
infanc
main
reason
given
use
antibiot
children
almost
children
least
one
episod
acut
otiti
media
age
year
present
multipl
episod
estim
acut
otiti
media
episod
nurs
babi
case
bacteria
particular
three
organ
pneumonia
nontypifi
h
influenza
catarrhali
amoxicillin
consid
drug
choic
treat
acut
otiti
media
base
pharmacokinet
pharmacodynam
principl
adequ
spectrum
excel
penetr
middl
ear
low
toxic
low
cost
howev
due
mani
case
acut
otiti
media
resolv
spontan
well
concern
excess
use
antibiot
mani
region
recommend
treat
acut
otiti
media
antibiot
unless
children
present
high
fever
persist
sign
symptom
given
analges
hour
netherland
children
acut
otiti
media
given
antibiot
usa
australia
rate
metanalysi
eight
studi
compris
children
acut
otiti
media
found
antibiot
superior
placebo
reliev
symptom
within
first
hour
treatment
reduc
pain
case
two
seven
day
clinic
condit
resolv
spontan
untreat
children
estim
benefit
antibiot
use
estim
show
symptom
resolv
one
child
treat
antibiot
symptom
acut
otiti
media
resolv
children
hour
two
three
day
regardless
antibiot
treatment
one
signific
issu
assess
children
otalgia
differenti
acut
otiti
media
otiti
media
effus
due
lower
complic
rate
diagnosi
acut
otiti
media
base
abrupt
onset
otalgia
fever
fluid
middl
ear
tympan
membran
bulg
decreas
absent
tympan
membran
mobil
fluid
level
behind
tympan
membran
acut
otorrhea
erythemat
membran
differenti
diagnosi
acut
otiti
media
otiti
media
effus
alway
easi
especi
physic
exam
done
feverish
irrit
cri
child
upper
airway
infect
sinc
cri
also
associ
tympan
membran
erythema
ad
concern
immedi
consequ
acut
otiti
media
complic
recurr
doubt
persist
whether
antibiot
affect
resolut
middl
ear
effus
lack
treatment
affect
hear
children
present
otiti
media
effus
acut
otiti
media
progress
well
estim
middl
ear
effus
follow
episod
acut
otiti
media
resolv
within
one
month
case
resolv
within
three
month
case
otiti
media
effus
unknown
durat
resolut
month
month
case
chronic
otiti
media
effus
resolut
somewhat
slower
month
month
recent
publish
random
studi
progress
acut
otiti
media
reveal
resolut
middl
ear
effus
children
acut
otiti
media
occur
averag
day
treatment
amoxicillin
cefuroxim
axetil
start
condit
resolv
children
day
effus
children
unilater
acut
otiti
media
resolv
rapidli
day
children
bilater
effus
day
bilater
acut
otiti
media
strongli
associ
increas
risk
failur
therapi
two
week
regardless
antibiot
use
result
canadian
studi
design
compar
effect
amoxicillin
mgkgday
placebo
children
acut
otiti
media
reveal
respons
day
antibiot
treatment
placebo
group
amoxicillin
therapi
superior
placebo
effect
small
children
progress
well
without
antibiot
frequenc
pain
fever
first
two
day
antibiotictr
group
lower
recent
publish
studi
recommend
care
approach
treatment
acut
otiti
media
wasp
wait
see
prescript
approach
anoth
studi
children
age
month
year
mild
moder
acut
otiti
media
random
prompt
antibiot
treatment
antibiot
symptom
persist
n
famili
member
caretak
accept
well
type
guidanc
day
antibiotictr
children
normal
tympan
membran
compar
control
group
tympanometri
within
normal
limit
children
antibiotictr
group
children
control
group
fewer
failur
children
treat
promptli
antibiot
children
control
group
requir
antibiot
cost
antibiotictr
group
us
averag
us
averag
control
group
visit
emerg
room
school
work
absente
recurr
ident
group
author
conclud
instruct
use
antibiot
symptom
persist
compar
prompt
antibiot
use
reduc
antibiot
use
furthermor
prompt
antibiot
use
increas
oropharyng
colon
multiresist
pneumonia
strain
soon
cessat
treatment
still
anoth
studi
compris
children
acut
otiti
media
month
year
random
either
given
antibiot
symptom
persist
worsen
reliev
ibuprofen
wasp
approach
classic
approach
prompt
antibiot
analges
therapi
result
reveal
children
requir
antibiot
complic
wasp
approach
group
medic
use
associ
persist
fever
otalgia
littl
et
al
monitor
children
age
month
year
one
year
random
prompt
antibiot
therapi
group
conserv
approach
group
wasp
give
antibiot
symptom
persist
worsen
regardless
analges
treatment
acut
otiti
media
shortterm
progress
similar
group
except
children
two
previou
episod
acut
otiti
media
among
children
recurr
otalgia
first
three
month
vs
number
sequela
one
year
later
differ
group
children
treat
antibiot
data
suggest
prompt
antibiot
therapi
alter
progress
acut
otiti
media
american
academi
pediatr
tabl
recommend
prompt
antibiot
treatment
follow
condit
children
age
six
month
children
age
month
evid
sign
acut
otiti
media
high
fever
andor
intens
otalgia
child
reassess
condit
worsen
children
underli
diseas
immunocompromis
cleft
palat
malform
children
age
year
whose
symptom
regress
hour
symptomat
therapi
although
mani
studi
shown
children
otiti
treat
antibiot
improv
rapidli
complic
critic
level
conserv
approach
inclus
exclus
criteria
studi
alway
clear
mani
studi
includ
children
age
year
exactli
prone
complic
children
seek
medic
help
within
first
hour
onset
symptom
advis
wait
anoth
hour
start
antibiot
symptomat
children
alway
possibl
assur
children
return
reevalu
especi
emerg
care
unit
studi
indic
suppur
complic
mastoid
frequent
countri
restrict
use
antibiot
treatment
acut
otiti
media
sinc
complic
rare
sampl
size
need
larger
assur
differ
progress
children
acut
otiti
media
treat
antibiot
tabl
recommend
use
antibiot
acut
otiti
media
children
age
month
even
symptom
sever
fever
high
due
high
complic
risk
children
age
month
high
fever
within
last
hour
sever
otalgia
reassess
possibl
condit
worsen
children
age
month
fever
andor
intens
otalgia
condit
persist
worsen
hour
symptomat
therapi
children
predispos
diseas
acut
otiti
media
cleft
palat
genet
syndrom
immun
defici
antibiot
select
treat
acut
otiti
media
also
controversi
author
recommend
therapi
high
dose
amoxicillin
mgkg
day
author
suggest
usual
dose
mgkgday
enough
treat
children
live
commun
preval
penicillinresist
pneumonia
low
well
children
month
given
least
three
dose
heptaval
pneumococc
conjug
vaccin
area
preval
antibioticresist
strain
high
use
widespectrum
antibiot
cephalosporin
macrolid
becom
common
dosag
durat
treatment
also
vari
studi
indic
cephalosporin
azithromycin
day
may
effect
day
amoxicillin
higher
probabl
adhes
treatment
mani
recommend
base
studi
use
doubl
tympanocentesi
assess
whether
bacteria
erad
middl
ear
furthermor
studi
taken
place
countri
preval
bacteri
resist
high
unfortun
local
pattern
antibiot
resist
strain
colon
airway
children
remain
unknown
area
make
difficult
select
best
antibiot
regimen
treat
acut
otiti
media
essenti
bear
mind
antibiot
may
increas
resist
decid
upon
use
furthermor
widespectrum
antibiot
macrolid
new
cephalosporin
higher
ecolog
impact
costli
amoxicillin
reason
believ
best
approach
treatment
acut
otiti
media
restrict
antibiot
use
mild
acut
otiti
media
case
low
fever
littl
pain
long
child
may
reassess
shortterm
symptom
worsen
persist
necessari
initi
therapi
amoxicillin
usual
dose
except
would
children
risk
resist
infect
recent
antibiot
treatment
recur
otiti
immun
defici
use
drug
treat
acut
otiti
media
decongest
nonsteroid
antiinflammatori
drug
topic
nasal
oral
corticosteroid
also
controversi
drug
appear
provid
benefit
children
acut
otiti
media
may
caus
advers
event
although
topic
corticosteroid
singli
antibiot
may
effect
reduc
middl
era
effus
short
term
enough
inform
assess
longterm
efficaci
thu
recommend
children
sign
symptom
atop
diseas
clinic
histori
physic
exam
epidemiolog
data
essenti
diagnosi
tonsil
sinus
otiti
rapid
strep
test
detect
streptococc
antigen
oropharynx
made
avail
public
privat
healthcar
unit
given
poor
specif
clinic
criteria
differenti
viral
bacteri
tonsil
case
acut
bacteri
sinus
acut
otiti
media
progress
favor
without
antibiot
guidelin
prescrib
analgesicsantitherm
medic
nasal
hygien
first
measur
treatment
infect
approach
applic
children
age
month
comorbid
sign
symptom
sever
diseas
physician
lay
person
need
inform
natur
progress
upper
airway
infect
risk
excess
antibiot
use
children
time
children
need
prompt
access
reassess
symptom
persist
worsen
situat
antibiot
treatment
start
immedi
surveil
system
provid
inform
resist
pattern
pneumonia
h
influenza
strain
colon
airway
caus
acut
otiti
media
children
need
sinc
wide
local
season
variat
resist
antibiot
